Leiomyosarcoma (LMS) Not Yet Recruiting Phase 2 Trials for Doxorubicin (DB00997)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

Indication	Status	Phase
DBCOND0118909 (Leiomyosarcoma (LMS))	Not Yet Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT06277154	MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma	Treatment	Doxorubicin (DB00997) Ifosfamide (DB01181)